• News
  • SAN DIEGO
  • BioTech

Arena announces filing for marketing authorization of Belviq in Brazil

Arena Pharmaceuticals Inc. has announced that Eisai Laboratorios Ltda., a subsidiary of Eisai Inc., has filed for marketing authorization of Belviq as a treatment for chronic weight management with the Brazilian Health Surveillance Agency.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!